2. Apoptosis Cell Cycle/DNA Damage
  3. Apoptosis CDK
  4. CDK8-IN-13

CDK8-IN-13 is a potent, selective and orally active CDK8 inhibitor with an IC50 value of 51.9 nM. CDK8-IN-13 induces Apoptosis. CDK8-IN-13 decreases the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 shows antitumor activity.

For research use only. We do not sell to patients.

CDK8-IN-13 Chemical Structure

CDK8-IN-13 Chemical Structure

CAS No. : 918523-75-8

Size Price Stock Quantity
5 mg USD 90 In-stock
10 mg USD 120 In-stock
25 mg USD 220 In-stock
50 mg USD 340 In-stock
100 mg USD 500 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

CDK8-IN-13 Related Antibodies

Top Publications Citing Use of Products

View All CDK Isoform Specific Products:

View All Isoforms
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CDK8-IN-13 is a potent, selective and orally active CDK8 inhibitor with an IC50 value of 51.9 nM. CDK8-IN-13 induces Apoptosis. CDK8-IN-13 decreases the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 shows antitumor activity[1].

IC50 & Target[1]

CDK8

51.9 nM (IC50)

In Vitro

CDK8-IN-13 (compound 43; 1, 2.5, 5, 10 µM; 12 h) decreases the expression of p-STAT1 S727 and p-STAT5 S726 i a dose-dependent manner in HCT-116 cells[1].
CDK8-IN-13 (0, 1, 5, 10 µM; 48 h) induces apoptosis in a dose-dependent manner[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

CDK8-IN-13 Related Antibodies

Cell Proliferation Assay[1]

Cell Line: molm-13, HL-60, MV4-11, MGC-803, MDA-MB-231, A375, A549 cells
Concentration: 0-50 µM
Incubation Time:
Result: Showed antiproliferative activity with GC50s of 1.57, 1.00, 4.61, >50, >50, >50, >50 µM, respectively.

Western Blot Analysis[1]

Cell Line: HCT-116 cells
Concentration: 1, 2.5, 5, 10 µM
Incubation Time: 12 h
Result: Decreased the expression of p-STAT1 S727 and p-STAT5 S726, and suppressed the phosphorylation of STAT1 S727 induced by IFN-γ (10 ng/mL) in a dose-dependent manner.

Apoptosis Analysis[1]

Cell Line: HL-60 cells
Concentration: 0, 1, 5, 10 µM
Incubation Time: 48 h
Result: Induced approximately 7% and 36% apoptotic at concentrations of 5 and 10 μM, respectively.
In Vivo

CDK8-IN-13 (40, 80 mg/kg; p.o.; for 15 days) inhibits tumor growth in a dose-dependent manner in mouse[1].
Pharmacokinetic Parameters of CDK8-IN-13 in Sprague-Dawley rats[1].

dose/routes t1/2 (h) Tmax (h) MRT(h)/td> Cmax (µg/L) AUC0-∞ (μg/L × h) CL (mL/h/kg) F (%)
10 mg/kg (po) 1.40 1.00 2.47 206.1 434.09 17.12 28.00
2 mg/kg (iv) 0.81 0.083 1.50 230.7 310.02 7.05 /
Sprague-Dawley rats, 2 mg/kg iv; 10 mg/kg po[1]

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6-week-old Balb/C mice (C1498 cells)[1]
Dosage: 40, 80 mg/kg
Administration: P.o.; for 15 days
Result: Decreased the tumor growth with no significant weight loss, the expression of Ki67 decreased in a dose-dependent manner, the level of phosphorylation of STAT1 S727 in tumor tissues was downregulated.
Molecular Weight

237.26

Formula

C14H11N3O
CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=CC=CC(C2=CN=C3NC=CC3=C2)=C1)N
Shipping

Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 125 mg/mL (526.85 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.2148 mL 21.0739 mL 42.1479 mL
5 mM 0.8430 mL 4.2148 mL 8.4296 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.2148 mL 21.0739 mL 42.1479 mL 105.3696 mL
5 mM 0.8430 mL 4.2148 mL 8.4296 mL 21.0739 mL
10 mM 0.4215 mL 2.1074 mL 4.2148 mL 10.5370 mL
15 mM 0.2810 mL 1.4049 mL 2.8099 mL 7.0246 mL
20 mM 0.2107 mL 1.0537 mL 2.1074 mL 5.2685 mL
25 mM 0.1686 mL 0.8430 mL 1.6859 mL 4.2148 mL
30 mM 0.1405 mL 0.7025 mL 1.4049 mL 3.5123 mL
40 mM 0.1054 mL 0.5268 mL 1.0537 mL 2.6342 mL
50 mM 0.0843 mL 0.4215 mL 0.8430 mL 2.1074 mL
60 mM 0.0702 mL 0.3512 mL 0.7025 mL 1.7562 mL
80 mM 0.0527 mL 0.2634 mL 0.5268 mL 1.3171 mL
100 mM 0.0421 mL 0.2107 mL 0.4215 mL 1.0537 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

CDK8-IN-13 Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CDK8-IN-13918523-75-8ApoptosisCDKCyclin dependent kinaseHCT-116 cellsapoptosisorally activep-STAT1 S727p-STAT5 S726antitumorInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CDK8-IN-13
Cat. No.:
HY-149974
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.